Biologics Market Size to Surpass USD 699.5 Billion by 2032, exhibiting a CAGR of 7.8%

The latest report by IMARC Group, titled "𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐒𝐡𝐚𝐫𝐞, 𝐒𝐢𝐳𝐞, 𝐆𝐫𝐨𝐰𝐭𝐡, 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲, 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟐," offers a comprehensive analysis of the biologics market. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.

The global biologics market size reached 𝐔𝐒𝐃 𝟑𝟒𝟗.𝟔 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑. Looking forward, IMARC Group expects the 𝐦𝐚𝐫𝐤𝐞𝐭 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 𝟔𝟗𝟗.𝟓 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐚 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝐨𝐟 𝟕.𝟖% 𝐝𝐮𝐫𝐢𝐧𝐠 𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟐.

𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.imarcgroup.com/biologics-market/requestsample

𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

The global market is primarily driven by the increasing prevalence of chronic diseases, including cancer and autoimmune disorders. Moreover, continual advancements in biotechnology and molecular biology are enabling the development of innovative biologics. Additionally, the growing investment in research and development by pharmaceutical companies is leading to the introduction of new biologic drugs. Furthermore, government support through favorable regulatory frameworks is encouraging the market's growth. The rise in the adoption of personalized medicine, which often relies on biologics, is another contributing factor.

Besides, the increasing geriatric population worldwide is propelling the demand for biologics due to age-related diseases. Moreover, the growing trend toward biosimilars is creating cost-effective alternatives, expanding the market's reach. Strategic collaborations between biotech firms and research institutions are accelerating the production and availability of biologic treatments.

𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐜𝐨𝐩𝐞 𝐚𝐧𝐝 𝐆𝐫𝐨𝐰𝐭𝐡 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:

The scope of the market is broadening due to the rising trend toward precision medicine, which requires highly targeted biologic therapies. Moreover, the expansion of biologics into new therapeutic areas, such as rare diseases and neurological disorders, is enhancing market opportunities. The increasing focus on biosimilar development, offering cost-effective alternatives, is further widening the market.

Additionally, advancements in drug delivery systems, such as sustained-release biologics, are improving patient compliance and treatment outcomes, which positively impacts market expansion. The global biologics market is also experiencing geographic growth, with emerging markets in Asia-Pacific and Latin America showing significant potential due to improving healthcare infrastructure and increasing access to advanced treatments. Furthermore, technological innovations in manufacturing processes are improving production efficiency, thereby lowering costs, and increasing market availability.

𝐒𝐩𝐞𝐚𝐤 𝐭𝐨 𝐚𝐧 𝐀𝐧𝐚𝐥𝐲𝐬𝐭: https://www.imarcgroup.com/request?type=report&id=3883&flag=C

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• AbbVie Inc.
• Amgen Inc.
• AstraZeneca plc
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline plc
• Johnson & Johnson
• Merck KGaA
• Novartis AG
• Pfizer Inc.
• Sanofi

𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

Our report has categorized the market based on region, source, product, disease and manufacturing.

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐒𝐨𝐮𝐫𝐜𝐞:

• Microbial
• Mammalian
• Others

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭:

• Monoclonal Antibodies
• Vaccines
• Recombinant Proteins
• Antisense, RNAi and Molecular Therapy
• Others

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐃𝐢𝐬𝐞𝐚𝐬𝐞:

• Oncology
• Immunological Disorders
• Cardiovascular Disorders
• Hematological Disorders
• Others

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠:

• Outsourced
• In-House

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐑𝐞𝐠𝐢𝐨𝐧:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

𝐊𝐞𝐲 𝐡𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭:

• Market Performance (2018-2023)
• Market Outlook (2024-2032)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐒:

𝐈𝐌𝐀𝐑𝐂 𝐆𝐫𝐨𝐮𝐩
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.